AFP and hepatocellular carcinoma: Yunsheng Zhao (Zhao et al., 2017) found that in addition to classical biomarkers such as AFP and des-γ-carboxyprothrombin (DCP), newly discovered biomarkers for HCC include Golgi glycoprotein 73, glypican 3, transforming growth factor-β1, and insulin-like growth factor-II.